Prevalence and Risk Factors for Infection with Herpes Simplex Virus Type-1 and -2 among Lesbians

Sexually Transmitted Diseases

Volumn 30, Issue 12, 2003, Pages 890-895

  Marrazzo, Jeanne M ^a,b   Stine, Kathleen ^a   Wald, Anna ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BISEXUALITY; CLINICAL FEATURE; FEMALE; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HOMOSEXUALITY; HUMAN; INFECTION RISK; LESBIAN; MAJOR CLINICAL STUDY; PREVALENCE; RACE DIFFERENCE; RISK FACTOR; SERODIAGNOSIS; SEROPREVALENCE; SEX RATIO; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HOMOSEXUALITY, FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; WASHINGTON;

EID: 0345599012     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.OLQ.0000091151.52656.E5     Document Type: Article

References (32)

1. Corey L, Wald A. Genital herpes. In: Holmes KK, Sparling PF, Mardh P-A, eds. Sexually Transmitted Diseases, 3rd ed. New York: McGraw-Hill; 1999:285-312.
2. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1111.
3. Xu F, Schillinger JA, Sternberg MR, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis 2002; 185:1019-1024.
4. Wald A, Koutsky L, Ashley RL, et al. Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis 1997; 24:149-155.
5. Koelle DM, Wald A. Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother 2000; 45(suppl T3):1-8.
6. Langenberg AG, Corey L, Ashley RL, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341:1432-1438.
7. Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999; 12:1-8.
8. Krone MR, Wald A, Tabet SR, et al. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 2000; 30:261-267.
9. Russell DB, Tabrizi SN, Russell JM, et al. Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homo-sexual men in a primary care setting. J Clin Virol 2001; 22:305-313.
10. Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001; 358:1835-1842.
11. Laumann OGJ, Michael RT, Michael S. The Social Organization of Sexuality: Sexual Practices in the United States. Chicago: University of Chicago Press; 1994.
12. Sell RL, Wells JA, Wypij D. The prevalence of homosexual behavior and attraction in the United States, the United Kingdom and France: results of national population -based samples. Arch Sex Behav 1995; 24:235-248.
13. Kwakwa HA, Ghobrial MW. Female-to-female transmission of human immunodeficiency virus. Clin Infect Dis 2003; 36:e40-e41.
14. Marrazzo JM, Koutsky LA, Stine KL, et al. Genital human papillomavirus infection in women who have sex with women. J Infect Dis 1998; 178:1604-1609.
15. O'Hanlan KA, Crum CP. Human papillomavirus-associated cervical intraepithelial neoplasia following lesbian sex. Obstet Gynecol 1996; 88:702-703.
16. Ferris DG, Batish S, Wright TC, et al. A neglected lesbian health concern: cervical neoplasia. J Fam Pract 1996; 43:581-584.
17. Kellock D, O'Mahony CP. Sexually acquired metronidazole-resistant trichomoniasis in a lesbian couple. Genitourinary Medicine 1996; 72:60-61.
18. Campos-Outcalt D, Hurwitz S. Female-to-female transmission of syphilis: a case report. Sex Transm Dis 2002; 29:119-120.
19. Diamant A, Lever J, Schuster MA. Lesbians' sexual activities and efforts to reduce risks for sexually transmitted diseases. Journal of the Gay and Lesbian Medical Association 2000; 4:41-48.
20. Marrazzo JM, Koutsky LA, Eschenbach DA, et al. Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis 2002; 185:1307-1313.
21. Diamant AL, Schuster MA, McGuigan K, et al. Lesbians' sexual history with men: implications for taking a sexual history. Arch Intern Med 1999; 159:2730-2736.
22. Bauer GR, Welles SL. Beyond assumptions of negligible risk: sexually transmitted diseases and women who have sex with women. Am J Public Health 2001; 91:1282-1286.
23. Ashley R, Militoni J, Lee F, et al. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 & 2 in human sera. J Clin Microbiol 1988; 26:662-667.
24. Wutzler P, Doerr HW, Farber I, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol 2000; 61:201-207.
25. Robertson P, Schachter J. Failure to identify venereal disease in a lesbian population. Sex Transm Dis 1981; 8:75-76.
26. Edwards A, Thin RN. Sexually transmitted diseases in lesbians. Int J STD AIDS 1990; 1:178-181.
27. Lowhagen GB, Tunback P, Bergstrom T. Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol 2002; 82:118-120.
28. Lowhagen GB, Tunback P, Andersson K, et al. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect 2000; 76:179-182.
29. Scoular A, Norrie J, Gillespie G, et al. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ 2002; 324:1366-1367.
30. Puthavathana P, Kanyok R, Horthongkham N, et al. Prevalence of herpes simplex virus infection in patients suspected of genital herpes; and virus typing by type specific fluorescent monoclonal anti-bodies. J Med Assoc Thai 1998; 81:260-264.
31. Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis 2002; 35:S173-S182.
32. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652-1661.